Literature DB >> 7514304

Anergic self-reactive B cells present self antigen and respond normally to CD40-dependent T-cell signals but are defective in antigen-receptor-mediated functions.

J M Eris1, A Basten, R Brink, K Doherty, M R Kehry, P D Hodgkin.   

Abstract

B-cell tolerance to soluble protein self antigens such as hen egg lysozyme (HEL) is mediated by clonal anergy. Anergic B cells fail to mount antibody responses even in the presence of carrier-primed T cells, suggesting an inability to activate or respond to T helper cells. To investigate the nature of this defect, B cells from tolerant HEL/anti-HEL double-transgenic mice were incubated with a membrane preparation from activated T-cell clones expressing the CD40 ligand. These membranes, together with interleukin 4 and 5 deliver the downstream antigen-independent CD40-dependent B-cell-activating signals required for productive T-B collaboration. Anergic B cells responded to this stimulus by proliferating and secreting antibody at levels comparable to or better than control B cells. Furthermore, anergic B cells presented HEL acquired in vivo and could present the unrelated antigen, conalbumin, targeted for processing via surface IgD. In contrast, the low immunoglobulin receptor levels on anergic B cells were associated with reduced de novo presentation of HEL and a failure to upregulate costimulatory ligands for CD28. These defects in immunoglobulin-receptor-mediated functions could be overcome in vivo, suggesting a number of mechanisms for induction of autoantibody responses.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7514304      PMCID: PMC43791          DOI: 10.1073/pnas.91.10.4392

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  Antigen-specific interaction between T and B cells.

Authors:  A Lanzavecchia
Journal:  Nature       Date:  1985 Apr 11-17       Impact factor: 49.962

2.  B7, a B-cell-restricted antigen that identifies preactivated B cells.

Authors:  A S Freedman; G Freeman; J C Horowitz; J Daley; L M Nadler
Journal:  J Immunol       Date:  1987-11-15       Impact factor: 5.422

3.  Stimulation of B-cell proliferation by membrane-associated molecules from activated T cells.

Authors:  A A Brian
Journal:  Proc Natl Acad Sci U S A       Date:  1988-01       Impact factor: 11.205

4.  Antigen presentation by normal B cells, B cell tumors, and macrophages: functional and biochemical comparison.

Authors:  R W Chesnut; S M Colon; H M Grey
Journal:  J Immunol       Date:  1982-04       Impact factor: 5.422

5.  Increased expression of I-region-associated antigen (Ia) on B cells after cross-linking of surface immunoglobulin.

Authors:  J J Mond; E Seghal; J Kung; F D Finkelman
Journal:  J Immunol       Date:  1981-09       Impact factor: 5.422

6.  Allotypic specificities of murine IgD and IgM recognized by monoclonal antibodies.

Authors:  A M Stall; M R Loken
Journal:  J Immunol       Date:  1984-02       Impact factor: 5.422

7.  Blocking of delivery of the antigen-mediated signal to the nucleus of T cells by cyclosporine.

Authors:  P D Hodgkin; A J Hapel; R M Johnson; I G Young; K J Lafferty
Journal:  Transplantation       Date:  1987-05       Impact factor: 4.939

8.  Expression and functional properties of mouse B7/BB1 using a fusion protein between mouse CTLA4 and human gamma 1.

Authors:  P Lane; W Gerhard; S Hubele; A Lanzavecchia; F McConnell
Journal:  Immunology       Date:  1993-09       Impact factor: 7.397

9.  Identification of the T-cell and Ia contact residues of a T-cell antigenic epitope.

Authors:  P M Allen; G R Matsueda; R J Evans; J B Dunbar; G R Marshall; E R Unanue
Journal:  Nature       Date:  1987 Jun 25-Jul 1       Impact factor: 49.962

10.  Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies.

Authors:  H M Cherwinski; J H Schumacher; K D Brown; T R Mosmann
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

View more
  30 in total

Review 1.  Understanding B-cell tolerance through the use of immunoglobulin transgenic models.

Authors:  Kirthi Raman Kumar; Chandra Mohan
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

2.  Potentially autoreactive naturally occurring transitional T3 B lymphocytes exhibit a unique signaling profile.

Authors:  Ganna A Liubchenko; Holly C Appleberry; V Michael Holers; Nirmal K Banda; Van C Willis; Taras Lyubchenko
Journal:  J Autoimmun       Date:  2012-02-24       Impact factor: 7.094

3.  Activation of thyroid antigen-reactive B cells in recent onset autoimmune thyroid disease patients.

Authors:  Mia J Smith; Marynette Rihanek; Brianne M Coleman; Peter A Gottlieb; Virginia D Sarapura; John C Cambier
Journal:  J Autoimmun       Date:  2017-12-09       Impact factor: 7.094

Review 4.  Transplantation tolerance: don't forget about the B cells.

Authors:  A S Chong; S H Khiew
Journal:  Clin Exp Immunol       Date:  2017-02-28       Impact factor: 4.330

5.  Role of molecular mimicry and polyclonal cell activation in the induction of pathogenic β2-glycoprotein I-directed immune response in Balb/c mice upon hyperimmunization with tetanus toxoid.

Authors:  Marijana Stojanović; Vladimir Petrušić; Irena Zivković; Aleksandra Inić-Kanada; Ivana Stojićević; Emilija Marinković; Ljiljana Dimitrijević
Journal:  Immunol Res       Date:  2013-05       Impact factor: 2.829

6.  B cells from African American lupus patients exhibit an activated phenotype.

Authors:  Laurence C Menard; Sium Habte; Waldemar Gonsiorek; Deborah Lee; Dana Banas; Deborah A Holloway; Nataly Manjarrez-Orduno; Mark Cunningham; Dawn Stetsko; Francesca Casano; Selena Kansal; Patricia M Davis; Julie Carman; Clarence K Zhang; Ferva Abidi; Richard Furie; Steven G Nadler; Suzanne J Suchard
Journal:  JCI Insight       Date:  2016-06-16

7.  Antigen-specific suppression of humoral immunity by anergic Ars/A1 B cells.

Authors:  Katja Aviszus; Megan K L Macleod; Greg A Kirchenbaum; Thiago O Detanico; Ryan A Heiser; James B St Clair; Wenzhong Guo; Lawrence J Wysocki
Journal:  J Immunol       Date:  2012-09-24       Impact factor: 5.422

8.  Virus-like display of a neo-self antigen reverses B cell anergy in a B cell receptor transgenic mouse model.

Authors:  Bryce Chackerian; Marisa R Durfee; John T Schiller
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422

9.  Tolerant anti-insulin B cells are effective APCs.

Authors:  Peggy L Kendall; James B Case; Allison M Sullivan; Jeff S Holderness; K Sam Wells; Edwin Liu; James W Thomas
Journal:  J Immunol       Date:  2013-02-08       Impact factor: 5.422

Review 10.  B cell abnormalities in systemic lupus erythematosus.

Authors:  Amrie C Grammer; Peter E Lipsky
Journal:  Arthritis Res Ther       Date:  2003-12-02       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.